38
Views
44
CrossRef citations to date
0
Altmetric
Journal Article

Diet-gene interactions in human lipoprotein metabolism.

&
Pages 313-324 | Published online: 04 Sep 2013

References

  • GrundySM, DenkeMA: Dietary influences on serum lipids in lipoproteins. J Lipid Res 31: 1149–1172, 1990.
  • MahleyRW: Apolipopratein E: cholesterol transport protein with expanding role in cell biology. Science 240: 622–630, 1988.
  • SingCF, DavignonJ: Role of the apolipopratein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 37: 268–285, 1985.
  • EtoM, WatanabeK, IshiiK: Reciprocal effects and apolipoprotein E alleles (E2 and E4) on plasma lipid levels in normolipidemic subjects. Clin Genet 29: 477–484, 1986.
  • UtermannG: Apolipoprotein E polymorphism in health and disease. Am Heart J 113: 433–440, 1987.
  • BoerwinkleE, VisvikisS, WelshD, SteinmetzJ, HanashSM, SingCF: The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individuals. Am J Med Genet 27: 567–582, 1987.
  • BoerwinkleE, UtermannG: Simultaneous effects of the apolipoprotein E polymorphism on apolopoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Hum Genet 42: 104–112, 1988.
  • DavignonJ, GreggRE, SingCF: Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8: 1–21, 1988.
  • KoboriS, NakamuraN, UzawaH, ShichiriM: Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan. Atherosclerosis 69: 81–88, 1988.
  • EichnerJE, KullerLH, FerrellRE, KambohMI: Phenotypic effects of apolipoprotein structural variation on lipid profiles. IV. Apolipoprotein polymorphism in a small group of black women from healthy women study. Genet Epidemiol 6: 681–689, 1989.
  • EichnerJE, KullerLH, FerrellRE, MeilahnEN, KambohMI: Phenotypic effects of apolipoprotein structural variation on lipid profiles. III. Contribution of apolipoprotein E phenotype to prediction of total cholesterol, apolipoprotein B, and low density lipoprotein cholesterol in the healthy women study. Arteriosclerosis 10: 379–385, 1990.
  • XuCF, BoerwinkleE, TikkanenMJ, HuttunenJK, HumphriesSE, TalmudPJ: Genetic variation at the apolipoprotein gene loci contribute to response of plasma lipids to dietary change. Genet Epidemiol 7: 261–275, 1990.
  • ShriverMD, BoerwinkleE, Hewett-EmmettD, HanisCL: Frequency and effects of apolipoprotein E polymorphism in Mexican-American NIDDM subjects. Diabetes 40: 334–337, 1991.
  • XhignesseM, Lussier-CacanS, SingCF, KesslingAM, DavignonJ: Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arterioscler Thromb 11: 1100–1110, 1991.
  • DallongevilleJ, Lussier-CacanS, DavignonJ: Modulation of plasma triglyceride levels by apoE phenotype: A meta-analysis. J Lipid Res 33: 447–454, 1992.
  • SchaeferEJ, Lamon-FavaS, JohnsonS, OrdovasJM, SchaeferMM, CastelliWP, WilsonPWF: Effects of gender and menopause status on the association of apolipoprotein E phenotype with plasma lipoprotein levels: results from the Framingham offspring study. Arterioscler Thromb 14: 1105–1113, 1994.
  • ReillySL, FerrellRE, SingCF: The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, MN: III. Correlations and covariances. Am J Hum Genet 55: 1001–1018, 1994.
  • MillerNE: Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 113: 589–597, 1987.
  • HixsonJE: Apolipoprotein E polymorphisms affect atherosclerosis in young males: pathobiological determinants of atherosclerosis in youth (PDAY) research group. Arterioscler Thromb 11: 1237–1244, 1991.
  • EichnerJE, KullerLH, OrchardTJ, GranditsGA, McCallumLM, FerrellRE, NeatonJD: Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol 71: 160–165, 1993.
  • TiretL, de KnijffP, MenzelH-J, EhnholmC, NicaudV, HavekesL: ApoE polymorphism and redisposition to coronary heart disease in youths of different european populations. The EARS study. Arterioscler Thromb 14: 1617–1624, 1994.
  • LucG, BardJ-M, ArveilerD, EvansA, CambouJ-P, BinghamA, AmouyelP, SchafferP, RuidavetsJ-B, CambienF, FruchartJ-C, DucimetiereP: Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction: The ECTIM Study. Arterioscler Thromb 14: 1412–1419, 1994.
  • StengardJH, ZerbaKE, PekkanenJ, EhnholmC, NissinenA, SingCF: Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 91: 265–269, 1995.
  • PairitzG, DavignonJ, MaillouxH, SingCF: Sources of interindividual variation in the quantitative levels of apolipoprotein B in pedigrees ascertained through a lipid clinic. Am J Hum Genet 43: 311–321, 1988.
  • SmitM, De KnijffP, RosseneuM, BuryJ, KlasenE, FrantsR, HavekesL: Apolipoprotein E polymorphism in the Netherlands and its effect on plasma lipid and apolipoprotein levels. Hum Genet 80: 287–292, 1988.
  • EtoM, WatanabeK, ChonanN, IshiiK: Familial hypercholesterolemia and apolipoprotein E4. Atherosclerosis 72: 123–128, 1988.
  • KuusiT, NieminenMS, EhnholmC, YkiJH, ValleM, NikkiläEA, TaskinenMR: Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis 9: 237–241, 1989.
  • DallongevilleJ, RoyM, LeboeufN, XhignesseM, DavignonJ, Lussier-CacanS: Apolipoprotein E polymorphism association with lipoprotein profile in endogenous hypertriglyceridemia and familial hypercholesterolemia. Arteriosclerosis 11: 272–278, 1991.
  • KambohMI, SepehrniaB, FerrellRE: Genetic studies of human apolipoproteins VI. Common polymorphism of apolipoprotein E in blacks. Disease Markers 7: 49–55, 1989.
  • EhnholmC, LukkaM, KuusiT, NikkilaE, UtermannG: Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 27: 227–235, 1986.
  • LehtimakiT, MoilanenT, ViikariJ, ÅkerblomHK, EhnholmC, RönnemaaT, MarniemiJ, DahlenG, NikkariT: Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. J Lipid Res 31: 487–495, 1990.
  • KuusiT, TaskinenM-R, SolakiviT, Kauppinen-MakelinR. Role of apolipoproteins E and C in type V hyperlipoproteinemia. J Lipid Res 29: 293–298, 1988.
  • MiectinenTA, KesäniemiYA: Cholesterol absorption: regulation of cholesterol synthesis and elimination and within-population variations of serum cholesterol levels. Am J Clin Nutr 49: 629–635, 1989.
  • TikkanenMJ, HuttunenJK, EhnholmC, PietinenP: Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high-fat diet. Arteriosclerosis 10: 285–288, 1990.
  • MänttäriM, KoskinenP, EhnholmC, HuttunenJK, ManninenV: Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention. Metabolism 40: 217–221, 1991.
  • LehtimäkiT, MoilanenT, SolakiviT, LaippalaP, EhnholmC: Cholesterol-rich diet induced changes in plasma lipids in relation to apolipoprotein E phenotype in healthy students. Ann Med 24: 61–66, 1992.
  • MiettinenTA, GyllingH, VanhanenH, OllusA: Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes. Arterioscler Thromb 12: 1044–1052, 1992.
  • CobbMM, TeitlebaumHS, RischN, JekelJJ, OstfeldAM: Influence of dietary fat, apolipoprotein E phenotype, and sex on plasma lipoprotein levels. Circulation 86: 849–857, 1992.
  • Lopez-MirandaJ, OrdovasJM, MataP, LichtensteinAH, ClevidenceB, JuddJT, SchaeferEJ: Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. J lipid Res 35: 1965–1975, 1994.
  • DreonDM, FernstromHA, MillerB, KraussRM: Apolipoprotein E isoform phenotype and LDL subclass response to a reduced-fat diet. Arterioscler Thromb Vasc Biol 15: 105–111, 1995.
  • CliftonPM, KestinM, AbbeyM, DrysdaleM, NestelPJ: Relationship between sensitivity to dietary fat and dietary cholesterol. Arteriosclerosis 10: 394–401, 1990.
  • BoerwinkleE, BrownSA, RohrbachK, GottoAMJr., PatschW: Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol. Am J Hum Genet 49: 1145–1154, 1991.
  • GlatzJFC, DemackerPNM, TurnerPR, KatanMB: Response of serum cholesterol to dietary cholesterol in relation to apolipoprotein E phenotype. Nutr Metab Cardiovasc Dis 1: 13–17, 1991.
  • SavolainenMJ, RantalaM, KervinenK, JarviL, SuvantoK, RantalaT, KesaniemiYA: Magnitude of dietary effects on plasma cholesterol concentration: Role of sex and apolipoprotein E phenotype. Atherosclerosis 86: 145–152, 1991.
  • CobbMM, RischN: Low-density lipoprotein cholesterol responsiveness to diet in normolipidemic subjects. Metabolism 42: 7–13, 1993.
  • SarkkinenES, UusitupaMU, PietinenP, AroA, AholaI, PenttilaI, KervinenK, KesaniemiYA: Long-term effects of three fat-modified diets in hypercholesterolemic subjects. Atherosclerosis 105: 9–23, 1994.
  • ZambonD, RosE, CasalsE, SanllehyC, BertomeuA, CamperoI: Effect of apolipoprotein E polymorphism on the serum lipid response to a hypolipidemic diet rich in monounsaturated fatty acids in patients with hypercholesterolemia and combined hy perlipidemia. Am J Clin Nutr 61: 141–148, 1995.
  • MiettinenTA, GyllingH, VanhanenH: Serum cholesterol response to dietary cholesterol and apoprotein E phenotype. Lancet 2: 1261, 1988.
  • FriedlanderY, BerryEM, EisenbergS, SteinY, LeitersdorfE: Plasma lipids and lipoproteins response to a dietary challenge: analysis of four candidate genes. Clin Genet 47: 1–12, 1995.
  • UusitupaMIJ, RuuskanenE, MäkinenE, LaitinenJ, ToskalaE, KervinenK, KesäniemiYA: A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to apolipoprotein E phenotype. J Am Coll Nutr 11: 651–659, 1992.
  • JenkinsDJA, HegeleRA, JenkinsAL, ConnellyPW, HallakK, BracciP, KashtanH, CoreyP, PintiliaM, SternH, BruceR: The apolipoprotein E gene and the serum low-density lipoprotein cholesterol response to dietary fiber. Metabolism 42: 585–593, 1993.
  • EhnholmC, HuttunenJK, PietinenP: Effect of diet on serum lipoproteins in a population with a high risk of coronary heart disease. N Engl J Med 307: 850–855, 1982.
  • SepehrniaB, KambohMI, AdamsCL, BunkerCH, NwankwoM, MajumderPP, FerrellRE: Genetic studies of human apolipoproteins. X. The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian blacks. Am J Hum Genet 45: 586–591, 1989.
  • SepehmiaB, KambohMI, Adams-CampbellLL, NwankwoM, FerrellRE: Genetic studies of human apolipoproteins. VII. Population distribution of polymorphism of apolipoproteins A-I, A-II, A-IV, C-II, E, and H in Nigeria. Am J Hum Genet 43: 847–853, 1988.
  • WeintraubMS, EisenbergS, BreslowJL: Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 80: 1571–1577, 1987.
  • DemantT, BedfordD, PackardCJ, ShepherdJ: Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects. J Clin Invest 88: 1490–1501, 1991.
  • SehayekE, EisenbergS: Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J Biol Chem 266: 18259–18267, 1991.
  • GyllingH, MiettinenTA: Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men with different apoE phenotypes. J Lipid Res 33 1361–1371, 1992.
  • BrenninkmeijerBJ, StuytPMJ, DemackerPNM, StalenhoefAFH, van't LaarA: Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype. J Lipid Res 28: 361–370, 1987.
  • BrownAJ, RobertsDCK: The effect of fasting triacylglyceride concentration and apolipoprotein E polymorphism on postprandial lipemia. Arteriosc Ier Thromb 11: 1737–1744, 1991.
  • NikkiläM, SolakiviT, LehtimäkiT, KoivulaT, LaippalaP, AstromB: Postprandial plasma lipoprotein changes in relation to apolipoprotein E phenotypes and low density lipoprotein size in men with and without coronary artery disease. Atherosclerosis 106: 149–157, 1994.
  • GreggRE, ZechLA, SchaeferEJ, StarkD, WilsonD, BrewerHBJr: Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest 78: 815–821, 1986.
  • SuperkoHR, HaskellWL: The effect of apolipoprotein E isoform difference on postprandial lipoprotein composition in patients matched for triglycerides, LDL-cholesterol, and HDL-cholesterol. Artery 18: 315–325, 1991.
  • BoerwinkleE, BrownS, SharrettJR, HeissG, PatschW: Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations. Am J Hum Genet 54: 341–360, 1994.
  • KesšniemiYA, EhnholmC, MiettinenTA: Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 80: 578–581, 1987.
  • MiettinenTA, VanhanenH: Dietary sitostanol related to absorption, synthesis and serum level of cholesterol in different apolipoprotein E phenotypes. Atherosclerosis 105: 217–226, 1994.
  • WeisgraberKH, InnerarityTL, MahleyRW: Abnormal lipoprotein receptor-binding activity of the human apoprotein E due to cysteine-arginine interchange at a single site. J Biol Chem 257: 2518–2521, 1982.
  • LingaV, LeightMA, CurtissLK, MarcelYL, St. ClairRW, ParksJS: Dietary fish oil-induced decrease in low density lipoprotein binding to fibroblasts is mediated by apolipoprotein E. J Lipid Res 35: 491–500, 1994.
  • RoeRP, JonesPJH, FrohlichJJ: Association between apolipoprotein E phenotype and endogenous cholesterol synthesis as measured by deuterium uptake. Cardiovasc Res 25: 249–255, 1991.
  • PalmerRH, NicholsAV, DellRB, RamakrishnanR, LindgrenFT, GongEL, BlumCB, GoodmanDS: Lack of relationship in humans of the parameters of body cholesterol metabolism with plasma levels of subtractions of HDL or LDL, or with apoE isoform phenotype. J Lipid Res 27: 637–644, 1986.
  • JonesPJH, MainBF, FrohlichJJ: Response of cholesterol synthesis to cholesterol feeding in men with different apolipoprotein E genotypes. Metabolism 42: 1065–1071, 1993.
  • WilliamsPT, DreonDM, KraussRM: Effects of dietary fat on high-density lipoprotein subclasses are influenced by both apolipoprotein E isoforms and low-density lipoprotein subclass pattern. Am J Clin Nutr 61: 1234–1240, 1995.
  • MartinLJ, ConnellyPW. NancooD, WoodN, ZhangZJ, MaguireG, QuinetE, TallAR, MarcelYL, McPhersonR: Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype. J Lipid Res 34: 437–446, 1993.
  • WeisgraberKH: Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. J Lipid Res 31: 1503–1512, 1990.
  • TozukaM, HidakaH, MiyachiM, FurihataK, KatsuyamaT, KanaiM: Identification and characterization of apolipoprotein(AII-E2-AII) complex in human plasma lipoprotein. Biochim Biophys Acta Lipids Lipid Metab 1165: 61–67, 1992.
  • GreenPH, GlickmanRM, RileyJW, QuinetE: Human apolipoprotein A-IV; intestinal origin and distribution in plasma. J Clin Invest 65: 911–919, 1980.
  • RyeKA, GarretyKH, BarterPJ: Changes in the size of reconstituted high density lipoproteins during incubation with cholesteryl ester transfer protein: The role of apolipoproteins. J Lipid Res 33: 215–224, 1992.
  • SteinmetzA, BarbarasR, GhalimN, ClaveyV, FruchartJC, AilhaudG: Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. J Biol Chem 265: 7859–7863, 1990.
  • LohseP, KindtMR, RaderDJ, BrewerHJ: Genetic polymorphism of human plasma apolipoprotein A-IV is due to nucleotide substitutions in the apolipoprotein A-IV gene. J Biol Chem 265: 10061–10064, 1990.
  • MenzelH-J, BoerwinkleE, Schrangl-WillS, UtermannG: Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels. Hum Genet 79: 368–372, 1988.
  • MenzelHJ, SigurdssonG, BoerwinkleE, SchranglWS, DieplingerH, UtermannG: Frequency and effect of human apolipoprotein A-IV polymorphism on lipid and lipoprotein levels in an Icelandic population. Hum Genet 84: 344–346, 1990.
  • de KnijffP, RosseneuM, BeisiegelU, de KeersgieterW, FrantsRR, HavekesLM: Apolipoprotein A-IV polymorphism and its effect on plasma lipid and apolipoprotein concentrations. J Lipid Res 29: 1621–1627, 1988.
  • HanisCL, DouglasTC, Hewett-EmmettD: Apolipoprotein A-IV protein polymorphism: Frequency and effects on lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas. Hum Genet 86: 323–325, 1988.
  • KaprioJ, FerrellRE, KottkeBA, KambohMI, SingCF: Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. Arterioscler Thromb 11: 1330–1348, 1991.
  • Von EckardsteinA, FunkeH, SchulteM, ErrenM, SchulteH, AssmannG: Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population. Am J Hum Genet 50: 1115–1128, 1992.
  • McCombsRJ, MarcadisDE, EllisJ, WeinbergRB: Attenuated hypercholesterolemic response to a high-cholesterol diet in subjects heterozygous for the apolipoprotein A-IV-2 allele. N Engl J Med 331: 706–710, 1994.
  • MataP, OrdovasJM, Lopez-MirandaJ, LichtensteinAH, ClevidenceB, JuddJT, SchaeferEJ. ApoA-IV phenotype affects diet-induced plasma LDL cholesterol lowering. Arterioscler Thromb 14: 884–891, 1994.
  • RaderDJ, SchaferJ, LohseP, VergesB, KindtM, ZechLA, SteinmetzA, BrewerHBJ: Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catablism of the apo A-IV-2 isoprotein. J Clin Invest 92: 1009–1017, 1993.
  • WeinbergRB, JordanMK, SteinmetzA: Distinctive structure and function of human apolipoprotein variant Apo A-IV-2. J Biol Chem 265: 18372–18378, 1990.
  • BarterP: High density lipoproteins and reverse cholesterol transport Curr Opin Lipidol 4: 210–217, 1993.
  • LeeDM, DashtiN, MokT: Apolipoprotein B-100 is the major form of this apolipoprotein secreted by human intestinal Caco-2 cells. Biochem Biophys Res Comm 156: 581–587, 1988.
  • MahleyRW, InnerarityTL: Lipoprotein receptors and cholesterol homeostasis. Biochim Biophys Acta 737: 197–222, 1983.
  • BrownMS, GoldsteinJL: A receptor-mediated pathway for cholesterol homeostatis. Science 232: 34–47, 1986.
  • Tybj3/4rg-HansenA, NordestgaardBG: Apolipoprotein B genotypes predict atherosclerosis and hyperlipidemia. Circulation 82 Suppl. III: III-621, 1990.
  • GenestJJ, OrdovasJM, McNamaraJR. RobbinsAM, MeadeT, CohnSD, SalemDN, WilsonP, MasharaniU, FrossardPM, SchaeferEJ: DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery disease. Atherosclerosis 82: 7–17, 1990.
  • BrunzellJD, SnidermanAD, AlbersJJ, KwiterovichPOJr: Apoproteins B and A-I and coronary heart disease in humans. Arteriosclerosis 4: 79–83, 1984.
  • LadiasJAA, KwiterovichPOJr., SmithHH, MillerM, BachorikPS, ForteT, LusisAJ, AntonarakisSE: Apolipoprotein B-100 Hopkins (arginine4019→tryptophan). A new apolipoprotein B-100 variant in a family with premature atherosclerosis and hyperapobetalipoproteinemia. JAMA 262: 1980–1988, 1989.
  • AustinMA, BreslowJL, HennekensCH, BuringJE, WillettWC, KraussRM: Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260: 1917–1921, 1988.
  • CrouseJR, ParksJS, ScheyHM, KohlFR: Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J. Lipid Res 26: 566–574, 1985.
  • Aalto-SetalaK, TikkanenMJ, TaskinenMR, NieminenM, HolmbergP, KontulaK: Xbal and c/g polymorphisms of the apolipoprotein B gene locus are associated with serum cholesterol and LDL-choles-terol levels in Finland. Atherosclerosis 74: 47–54, 1988.
  • GyllingH, Aalto-SetäläK, KontulaK, MiettinenTA: Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia. Arterioscler Thromb 11: 1368–1375, 1991.
  • HoulstonRS, TurnerPR, LewisB, HumphriesSE: Genetic epidemiology of differences in low-density lipoprotein (LDL) cholesterol concentration: Possible involvement of variation at the apolipoprotein B gene locus in LDL kinetics. Genet Epidemiol 7: 199–210, 1990.
  • BergK: DNA polymorphism at the apolipoprotein B locus is associated with lipoprotein level. Clin Genet 30: 515–520, 1986.
  • LawA, WallisSC, PowellLM, PeaseRJ, BruntH, PriesdyLM, KnottTJ, ScottJ, AltmanDG, MillerGJ, RajputJ, MillerNE: Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet 1: 1301–1303, 1986.
  • TalmudPJ, BarniN, KesslingAM, CarlssonP, DarnforsC, BjursellG, GaltonD, WynnV, KirkH, HaydenMR, HumphriesSE: Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in norm- and hyperlipidemic individuals. Atherosclerosis 67: 81–89, 1987.
  • Aalto-SetäläK, GyllingH, HelveE, KovanenP, MiettinenTA, TurtolaH, KontulaK: Genetic polymorphism of the apolipoprotein B gene locus influences serum LDL cholesterol level in familial hypercholesterolemia. Hum Genet 82: 305–307, 1989.
  • HegeleRA, HuangL-S, HerbertPN, BlumCB, BuringJB, HennekensCH, BreslowJL: Apolipoprotein B gene DNA polymorphisms associated with myocardial infarction. N Engl J Med 315: 1509–1515, 1986.
  • AburataniH, MatsumotoA, ItohH, YamadaN, MuraseT, TakakaF, ItakuraH: A study of DNA polymorphism in the apolipoprotein B gene in a Japanese population. Atherosclerosis 72: 71–76, 1988.
  • TikkanenMJ, XuC-F, HämäläinenT, TalmudP, SarnaS, HuttunenJK, PietinenP, HumphriesS: Xbal polymorphism of the apolipoprotein B gene influences plasma lipid response to diet intervention. Clinical Genetics 37: 327–334, 1990.
  • TalmudPJ, BoerwinkleE, XuC, TikkanenMJ, PietinenP, HuttunenJK, HumphriesS: Dietary intake and gene variation influence the response of plasma lipids to dietary intervention. Genet Epidemiol 9: 249–260, 1992.
  • AbbeyM, BellingB, CliftonP, NestelP: Apolipoprotein B gene polymorphism associates with plasma cholesterol changes induced by dietary fat and cholesterol. Nutr Metab Cardiovasc Dis 1: 10–12, 1991.
  • XuC, TikkanenMJ, HuttunenJK, PietinenP, BütlerR, HumphriesS, TalmudP: Apolipoprotein B signal peptide insertion/deletion polymorphism is associated with Ag epitopes and involved in the determination of serum triglyceride levels. J Lipid Res 31: 1255–1261, 1990.
  • HegeleRA, ZahariadisG, JenkinsAL, ConnellyPW, KashtanH, StemH, BruceR, JenkinsDJA: Genetic variation associated with differences in the response of plasma apolipoprotein B levels to dietary fibre. Clinical Science 85: 269–275, 1993.
  • IlmonenM, HelioT, ButlerR, PalotieA, PietinenP, HuttunenJK, TikkanenMJ: Two new immunogenetic polymorphisms of the apo B gene and their effect on serum lipid levels and responses to changes in dietary fat intake. Arterioscler Thromb Vasc Biol 15: 1287–1293, 1995.
  • Lopez-MirandaJ, OrdovasJM, EspinoA, MarinC, SalasJ, Lopez-SeguraF, Jimenez-PereperezJ, Perez-JimenezF: Influence of mutation in human apolipoprotein A-1 gene promoter on plasma LDL cholesterol response to dietary fat. Lancet 343: 1246–1249, 1994.
  • BoydNF, CousinsM, BeatonM, KriukovV, LockwoodG, TritchlerD. Quantitative changes in dietary fat intake and serum cholesterol in women: results from a randomized, controlled trial. Am J Clin Nutr 52: 470–476, 1990.
  • BeynenAC, KatanMB: Reproducibility of the variations between humans in the response of serum cholesterol to cessation of egg consumption. Atherosclerosis 57: 19–31, 1985.
  • KatanMB, BernsMAM, GlatzJFC, KnuimanJT, NobelsA, deVriesJHM: Congruence of individual responsiveness to dietery cholesterol and to saturated fat in humans. J Lipid Res 29: 883–892, 1988.
  • KeysA: Diet and blood cholesterol in population surveys—lessons from analysis of the data from a major survey in Israel. Am J Clin Nutr 48: 1161–1165, 1988.
  • KestinM, CliftonPM, RouseIL, NestelPJ: Effect of dietary cholesterol in normolipidemic subjects is not modified by nature and amount of dietary fat. Am J Clin Nutr 50: 528–532, 1989.
  • Applebaum-BowdenD, HaffherSM, HartsookE, LukKH, AlbersJJ, HazzardWR: Down-regulation of the low-density lipoprotein receptor by dietary cholesterol. Am J Clin Nutr 39: 360–367, 1984.
  • MeddingsJB, DietschyJM: Regulation of plasma levels of low-density lipoprotein cholesterol: interpretation of data on low-density lipoprotein turnover in man. Circulation 74: 805–814, 1986.
  • GyllingH, MiettinenTA: Absorption and metabolism of cholesterol in familial hypercholesterolaemia. Clin Sci 76: 297–301, 1989.
  • McNamaraDJ, KolbR, ParkerTS, BatwinH, SamuelP, BrownCD, AhrensEHJr: Heterogeneity of cholesterol homeostasis in man. J Clin Invest 79: 1729–1739, 1987.
  • JonesPJ, LichtensteinAH, SchaeferEJ: Interaction of dietary fat saturation and cholesterol level on cholesterol synthesis measured using deuterium incorporation. J Lipid Res 35: 1093–1101, 1994.
  • FieldFJ, KamNTP, MathurSN: Regulation of cholesterol metabolism in the intestine. Gastroenterology 99: 539–551, 1990.
  • SafonovaIG, SviridovDD, RoytmanA, RytikovFM, DolgovVV, NanoJL, RampalP, RepinVS: Cholesterol uptake in the human intestine. Hypo- and hyperresponsiveness. Biochim Biophys Acta Lipids Lipid Metab 1166: 313–316, 1993.
  • CraigWY, NutikR, CooperAD: Regulation of apoprotein synthesis and secretion in the human hepatoma Hep G2. The effect of exogenous lipoprotein. J Biol Chem 263: 13880–13890, 1988.
  • AustinMA, KingMC, VranizanKM, KraussRM: Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease risk. Circulation 82: 495–506, 1990.
  • CamposH, GenestJJJr, BlijlevensE, McNamaraJR, JennerJL, OrdovasJM, WilsonPWF, SchaeferEJ: Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 12: 187–195, 1992.
  • CoreshJ, KwiterovichPOJr, SmithHH, BachorikPS: Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res 34: 1687–1697, 1993.
  • AustinMA, KingMC, VranizanKM, NewmanB, KraussRM: Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet 43: 838–846, 1988.
  • AustinMA: Genetic epidemiology of low-density lipoprotein subclass phenotypes. Ann Med 24: 477–481, 1992.
  • NishinaPM, JohnsonJP, NaggertJK, KraussRM: Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. Proc Natl Acad Sci USA 89: 708–712, 1992.
  • RotterJ I, BuX, CantorR, WardenCH, BrownJ, GrayRJ, BlanchePJ, KraussRM, LusisAJ: Multilocus genetic determinants of LDL particle size in coronary artery disease families. Am J Hum Genet 58: 585–594, 1996.
  • AustinMA, NewmanB, SelbyJV, EdwardsK, MayerEJ, KraussRM: Genetics of LDL subclass phenotypes in women twins: Concordance, heritability, and commingling analysis. Arterioscler Thromb 13: 687–695, 1993.
  • CamposH, WillettWC, PetersonRM, SilesX, BaileySM, WilsonPWF, PosnerBM, OrdovasJM, SchaeferEJ: Nutrient intake comparisons between Framingham and rural and urban Puriscal, Costa Rica: Associations with lipoproteins, apolipoproteins, and low density lipoprotein particle size. Arterioscler Thromb 11: 1089–1099, 1991.
  • KraussRM, DreonDM: Low density lipoprotein subclasses and response to a low-fat diet in healthy men. Am J Clin Nutr 62: 478S–487S, 1995.
  • DreonDM, FemstromHA, MillerB, KraussRM: Low-density lipoprotein subclass patterns and lipoprotein response to a reduced-fat diet in men. FASEB J 8: 121–126, 1994.
  • KashyapML, BarnhartRL, SrivastavaLS, PerisuthG, VinkP, AllenC, HoggE, BradyD, GlueckCJ, JacksonRL: Effects of dietary carbohydrate and fat on plasma lipoproteins and apolipoproteins C-II and C-IIIin healthy men. J Lipid Res 23: 877–886, 1982.
  • GargA, BonanomeA, GrundySM, ZhangZ-J, UngerRH: Comparison of a high-carbohydrate diet with a high-monounsaturated fat diet in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 319: 829–834, 1988.
  • FisherWR. Heterogeneity of plasma low density lipoprotein: Manifestations of the physiologic phenomenon in man. Metabolism 32: 283–291, 1983.
  • DeckelbaumRJ, GranotE, OschryY, RoseL, EisenbergS: Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis 4: 225–231, 1984.
  • VegaGL, GrundySM: Kinetic heterogeneity of low density lipoproteins in primary hypertriglyceridemia. Arteriosclerosis 6: 395–406, 1986.
  • McNamaraJR, JennerJL, LiZ, WilsonPWF, SchaeferEJ: Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb 12: 1284–1290, 1992.
  • CamposH, DreonDM, KraussRM: Associations of hepatic and lipoprotein lipase activities with changes in dietary composition and low density lipoprotein subclasses. J Lipid Res 36: 462–472, 1995.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.